Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving management of optic neuritis and multiple sclerosis.

Anthony C Arnold1

  • 1Jules Stein Eye Institute, 100 Stein Plaza, Los Angeles, CA 90095-7005, USA. arnolda@ucla.edu

American Journal of Ophthalmology
|June 15, 2005
PubMed
Summary

Optic neuritis can indicate multiple sclerosis (MS). Early treatment with corticosteroids and immunomodulation agents (IMAs) may reduce the risk and severity of developing MS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Optical Coherence Tomography Angiography (OCTA) Analysis of Ischemic vs Non-Ischemic Optic Disc Edema.

Neuro-ophthalmology (Aeolus Press)·2025
Same author

Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Neurology·2025
Same author

Evolution of Disc Edema in Arteritic Anterior Ischemic Optic Neuropathy: Erratum.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2025
Same author

Eye Movements and the Intraorbital Subarachnoid Space: Potential Contribution of Altered Cerebrospinal Fluid Pumping in Optic Neuropathies.

Investigative ophthalmology & visual science·2025
Same author

Managing idiopathic intracranial hypertension in the eye clinic.

Eye (London, England)·2024

Area of Science:

  • Neuroimmunology
  • Ophthalmology
  • Neurology

Background:

  • Optic neuritis frequently presents as an initial symptom of multiple sclerosis (MS).
  • Magnetic resonance imaging (MRI) white matter lesions help predict the risk of developing MS after optic neuritis.
  • Axonal damage is now recognized as an early pathological feature in MS.

Purpose of the Study:

  • To examine the link between optic neuritis and MS.
  • To review therapeutic options for optic neuritis, focusing on visual and neurological outcomes.
  • To assess the efficacy of treatments for preventing MS development.

Main Methods:

  • Comprehensive literature review.
  • Analysis of clinical and laboratory evidence on optic neuritis and MS treatments.
  • Evaluation of corticosteroids, immunomodulation agents (IMAs), and other therapeutic modalities.

Main Results:

  • Corticosteroid therapy for optic neuritis offers minor, short-term visual recovery but no long-term visual benefits.
  • The combination of IMAs and corticosteroids significantly lowers the incidence of subsequent MS.
  • The risk of developing clinically definite MS (CDMS) is associated with MRI-detected demyelinative lesions.

Conclusions:

  • MS risk following optic neuritis is predictable.
  • Corticosteroids and IMAs, especially in high-risk individuals, decrease the likelihood and severity of CDMS.
  • Prompt, aggressive treatment for optic neuritis may prevent axonal damage and long-term MS disability.

Related Experiment Videos